Intelligence Β· Clinical Pipeline
Sinovac Research and Pipeline
All ClinicalTrials.gov programs at Sinovac Research and β phase, modality, and trial IDs.
- Programs
- 115
Quick answer
Sinovac Research and has 115 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Live attenuated varicella vaccine
Sinovac Research and Development Co.,
Varicella
3 trials -
Mumps vaccine
Sinovac Research and Development Co.,
Mumps
1 trial -
Mumps vaccine, Live (MV)
Sinovac Research and Development Co.,
Mumps
1 trial -
Pandemic influenza A/H1N1 vaccine
Sinovac Research and Development Co.,
Influenza
1 trial -
Quadrivalent Influenza Vaccine (Split Virion), inactivated
Sinovac Research and Development Co.,
Seasonal Influenza
1 trial -
SARS-CoV-2 Inactivated Vaccine
Sinovac Research and Development Co.,
COVID-19
2 trials -
The live attenuated varicella vaccine and the inactivated hepatitis A vaccine
Sinovac Research and Development Co.,
Varicella
1 trial -
Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.
Sinovac Research and Development Co.,
COVID-19
1 trial -
Two doses of quadrivalent influenza vaccine
Sinovac Research and Development Co.,
Seasonal Influenza
1 trial -
Vaicella Vaccine+DTaP on Day 0, MMR on Day 30
Sinovac Research and Development Co.,
Varicella (chickenpox)
1 trial -
Varicella vaccine
Sinovac Research and Development Co.,
VZV
1 trial -
Varicella vaccine+TIV
Sinovac Research and Development Co.,
Varicella
1 trial -
sIPV
Sinovac Research and Development Co.,
Poliomyelitis
3 trials -
sIPV vaccine /DTaP vaccine
Sinovac Research and Development Co.,
Poliomyelitis
1 trial -
seasonal split influenza vaccine
Sinovac Research and Development Co.,
Influenza
1 trial -
split-virion, adjuvanted H1N1 vaccine of 7.5 ΞΌg per dose
Sinovac Research and Development Co.,
Influenza
1 trial -
trivalent seasonal influenza vaccine
Sinovac Research and Development Co.,
Influenza
1 trial -
SA58 Nasal Spray
Sinovac Research and Development Co.,
COVID-19
2 trials -
Three doses of low-dosage investigational sIPV, vaccinated within one-month interval between doses
Sinovac Research and Development Co.,
Poliomyelitis
1 trial
Frequently asked questions
How many pipeline programs does Sinovac Research and have?
115 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources Β· All pipeline programs